Back to Journals » Journal of Blood Medicine » Volume 10

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)

Total article views   Abstract views HTML views PDF downloads Totals
4,240 Dovepress* 3,378 625+ 725 4,003
PubMed Central* 0 237 60 237
Totals 3,378 862 785 4,240
*Since 18 September 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar